Society ❯ Health Concerns ❯ Vaccine Skepticism

Public Perception

Efficacy Issues Media Influence Antivaccine Movement Disease Outbreaks Safety Inquiries Child Health Risks Thimerosal Controversy

U.S. Releases $600 Million to Gavi After Pact to Phase Out Mercury-Containing Vaccines

The move conditions U.S. support on Gavi’s pledge to transition away from thimerosal, increases U.S. oversight, excludes U.S. funding for WHO.

FDA Opens Safety Review of Infant RSV Antibody Drugs Beyfortus and Enflonsia